Odyssey Therapeutics has become the latest biotech to voyage to the public markets via an upsized $3...
Odyssey CEO sees $304M IPO creating ‘little large pharma’
Odyssey Therapeutics has become the latest biotech to voyage to the public markets via an upsized $304 million IPO this morning.
Author: Fierce Biotech
Read Original Article